An observational study in Keloid, sponsored by Tirgan, Michael H., M.D.. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-10-04.
Sponsored by Tirgan, Michael H., M.D. · Observational
This trial intends to gather very basic clinical information about keloid, its patterns of presentation, family history, ethnic background and correlation with the type of keloid, as well as prior treatment results that patients have had received.
This will be a web based study, whereby patients will have to read and acknowledge the consent form online. Once patients agree and acknowledge the terms of the consent form, they will gain access to the questionnaire pages.
For those who are under age of 18, a parent or a legal guardian must sign the consent form and answer the online questions on behalf of the patient.
138 studies on the registry are indexed under Keloid; 26 are open to participants now.
This study's planned enrollment of 10,000 is above the median of 100 across 23 observational studies indexed under Keloid.
Browse Keloid studies →Tirgan, Michael H., M.D. is the lead sponsor of 8 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with keloid disorder.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
All participants have a clinical diagnosis of keloid.
Determine the prevalence different phenotypes of keloid in participants.
Prevalence of different phenotypes of keloid will be measured in the study population and reported. Prevalence of familial keloid in the study population will also be determined and reported. Data will be analyzed to determine the distribution of keloid among different ethic groups. Data will be analyzed to report the percentage of patients who have had one or more treatments and the percentage of patients who have had successful treatments.
Time frame: Two years
Plan to share: Yes — All data will be shared and published
The record gives a start of Nov 2011, a primary completion of Dec 2030 and a completion of Jun 2031. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tirgan, Michael H., M.D.